These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26499396)
21. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer. Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180 [TBL] [Abstract][Full Text] [Related]
22. Abnormal extracellular matrix remodelling in the cervix of pregnant relaxin-deficient mice is not associated with reduced matrix metalloproteinase expression or activity. Marshall SA; McGuane JT; Soh YM; Gehring HM; Simpson E; Parry LJ Reprod Fertil Dev; 2018 Aug; 30(9):1214-1224. PubMed ID: 29533760 [TBL] [Abstract][Full Text] [Related]
23. D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. Kiessling A; Weigle B; Fuessel S; Ebner R; Meye A; Rieger MA; Schmitz M; Temme A; Bachmann M; Wirth MP; Rieber EP Prostate; 2005 Sep; 64(4):387-400. PubMed ID: 15761874 [TBL] [Abstract][Full Text] [Related]
24. Emerging roles for the relaxin/RXFP1 system in cancer therapy. Thanasupawat T; Glogowska A; Nivedita-Krishnan S; Wilson B; Klonisch T; Hombach-Klonisch S Mol Cell Endocrinol; 2019 May; 487():85-93. PubMed ID: 30763603 [TBL] [Abstract][Full Text] [Related]
25. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526 [TBL] [Abstract][Full Text] [Related]
26. Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells. Domińska K; Ochędalski T; Kowalska K; Matysiak-Burzyńska ZE; Płuciennik E; Piastowska-Ciesielska AW Int J Oncol; 2016 Jun; 48(6):2619-28. PubMed ID: 27035428 [TBL] [Abstract][Full Text] [Related]
27. Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection. Azam A; Gallais Y; Mallart S; Illiano S; Duclos O; Prades C; Maillère B J Immunol; 2019 Jun; 202(12):3507-3513. PubMed ID: 31101669 [TBL] [Abstract][Full Text] [Related]
28. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133 [TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in the promoter region of relaxin-2 and preterm birth: involvement of relaxin in the etiology of preterm birth. Vogel I; Hollegaard MV; Hougaard DM; Thorsen P; Grove J In Vivo; 2009; 23(6):1005-9. PubMed ID: 20023247 [TBL] [Abstract][Full Text] [Related]
31. Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF. Simon J; Nemeth E; Nemes A; Husveth-Toth M; Radovits T; Foldes G; Kiss L; Bagyura Z; Skopal J; Merkely B; Gara E Front Physiol; 2019; 10():690. PubMed ID: 31231242 [No Abstract] [Full Text] [Related]
32. Characterization, cDNA cloning and expression pattern of relaxin gene during embryogenesis of Danio rerio. Fiengo M; Donizetti A; del Gaudio R; Minucci S; Aniello F Dev Growth Differ; 2012 Jun; 54(5):579-87. PubMed ID: 22671140 [TBL] [Abstract][Full Text] [Related]
33. Endocrine effects of relaxin overexpression in mice. Feng S; Bogatcheva NV; Kamat AA; Truong A; Agoulnik AI Endocrinology; 2006 Jan; 147(1):407-14. PubMed ID: 16223865 [TBL] [Abstract][Full Text] [Related]
34. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721 [TBL] [Abstract][Full Text] [Related]
35. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502 [TBL] [Abstract][Full Text] [Related]
36. Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer. Seim I; Lubik AA; Lehman ML; Tomlinson N; Whiteside EJ; Herington AC; Nelson CC; Chopin LK J Mol Endocrinol; 2013 Apr; 50(2):179-91. PubMed ID: 23267039 [TBL] [Abstract][Full Text] [Related]
37. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. Bainbridge MN; Warren RL; Hirst M; Romanuik T; Zeng T; Go A; Delaney A; Griffith M; Hickenbotham M; Magrini V; Mardis ER; Sadar MD; Siddiqui AS; Marra MA; Jones SJ BMC Genomics; 2006 Sep; 7():246. PubMed ID: 17010196 [TBL] [Abstract][Full Text] [Related]
38. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M; Karry R; Weiss-Messer E; Barkey RJ Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305 [TBL] [Abstract][Full Text] [Related]
39. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551 [TBL] [Abstract][Full Text] [Related]
40. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models. Ateeq B; Vellaichamy A; Tomlins SA; Wang R; Cao Q; Lonigro RJ; Pienta KJ; Varambally S Prostate; 2012 Oct; 72(14):1542-9. PubMed ID: 22415461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]